Armistice Capital »

5e Advanced Materials shares owned by Armistice Capital

Quarter-by-quarter ownership of 5e Advanced Materials (FEAM) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in 5e Advanced Materials

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 292.6M2.65M4M4.5M5M
Value ($)Share countHistorical FEAM position of Armistice Capital Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including 5e Advanced Materials held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 5e Advanced Materials by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.6M 4.0M 0.64
2024-09-30 $2.7M 5.0M 0.54

More positions owned by Armistice Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Immunovant (IMVT)
Travere Therapeutics (TVTX)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
EXACT Sciences Corporation (EXAS)
Cytokinetics Com New (CYTK)
Vertex Pharmaceuticals Incorporated (VRTX)
Icon SHS (ICLR)
GSK Sponsored Adr (GSK)
Five9 (FIVN)
Inari Medical Ord (NARI)

View all positions for Armistice Capital

Top funds holding 5e Advanced Materials

Armistice Capital
Vanguard Group
Millennium Management
Macquarie Group
Geode Capital Management
BlackRock
Morgan Stanley
Wells Fargo & Company
UBS Group
State Street Corporation
Northern Trust
Citadel Advisors
Bridgeway Capital Management
Townsquare Capital
Summit Financial Strategies

View all funds holding 5e Advanced Materials